Federated Hermes
FLGT icon

Federated Hermes’s Fulgent Genetics FLGT Stock Holding History

Federated Hermes’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Hold
49,207
– – ﹤0.01% 1154
2026
Q1 		$782K Buy
49,207
+2,105
+4% +$45.7K ﹤0.01% 1181
2025
Q4 		$1.24M Buy
47,102
+552
+1% +$14.3K ﹤0.01% 1074
2025
Q3 		$1.05M Buy
46,550
+71
+0.2% +$1.46K ﹤0.01% 1126
2025
Q2 		$924K Hold
46,479
– – ﹤0.01% 1162
2025
Q1 		$785K Buy
46,479
+4,597
+11% +$78.3K ﹤0.01% 1174
2024
Q4 		$774K Buy
41,882
+1,774
+4% +$34.6K ﹤0.01% 1190
2024
Q3 		$872K Sell
40,108
-873
-2% -$19.5K ﹤0.01% 1172
2024
Q2 		$804K Buy
40,981
+3,374
+9% +$70.4K ﹤0.01% 1183
2024
Q1 		$816K Buy
37,607
+3,732
+11% +$92.7K ﹤0.01% 1202
2023
Q4 		$979K Sell
33,875
-9,715
-22% -$260K ﹤0.01% 1136
2023
Q3 		$1.17M Hold
43,590
– – ﹤0.01% 1063
2023
Q2 		$1.61M Sell
43,590
-28,712
-40% -$1M ﹤0.01% 1024
2023
Q1 		$2.26M Sell
72,302
-125,673
-63% -$4.04M 0.01% 920
2022
Q4 		$5.9M Buy
197,975
+197,428
+36,093% +$7.06M 0.02% 650
2022
Q3 		$21K Buy
547
+194
+55% +$9.73K ﹤0.01% 1765
2022
Q2 		$19K Sell
353
-285
-45% -$15.7K ﹤0.01% 1771
2022
Q1 		$40K Hold
638
– – ﹤0.01% 1764
2021
Q4 		$64K Sell
638
-808
-56% -$71K ﹤0.01% 1763
2021
Q3 		$130K Sell
1,446
-3,768
-72% -$342K ﹤0.01% 1739
2021
Q2 		$481K Buy
5,214
+3,730
+251% +$298K ﹤0.01% 1520
2021
Q1 		$144K Buy
1,484
+672
+83% +$69.4K ﹤0.01% 1742
2020
Q4 		$42K Buy
812
+372
+85% +$15.5K ﹤0.01% 1834
2020
Q3 		$18K Buy
+440
New +$13.8K ﹤0.01% 1908
2019
Q4 		– Sell
-99
Closed -$1K – 2239
2019
Q3 		$1K Buy
+99
New +$939 ﹤0.01% 2100

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes's FLGT Position: Q2 2026 in Review

Federated Hermes held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 49,207 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

Federated Hermes first reported a position in FLGT in Q3 2019 and has held it in 25 quarters since. The position peaked at $5.9M in Q4 2022. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Federated Hermes held 49,207 shares of Fulgent Genetics worth $1.01M as of Q2 2026.
  • Federated Hermes left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1154 holding.
  • Federated Hermes first reported a position in Fulgent Genetics in Q3 2019 and has held it in 25 quarters since.
  • Federated Hermes's Fulgent Genetics position peaked at $5.9M in Q4 2022.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.